FDA Hematology approvals in 2018

FDA highlights approvals in 2018 at recent ASH meeting in San Diego. 2018 saw 32 FDA approvals in hematology including 12 NMEs & 5 biosimilars. 8 had pediatric indications. 6 were for 1st-line indications.

https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm279174.htm

#FDA #Approvals #hematology #oncology #2018